Search

Your search keyword '"Chen, Y-C"' showing total 12 results
Start Over Author "Chen, Y-C" Journal oncogene
12 results on '"Chen, Y-C"'

9. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

Author

Wang, C-H, primary, Wang, P-J, additional, Hsieh, Y-C, additional, Lo, S, additional, Lee, Y-C, additional, Chen, Y-C, additional, Tsai, C-H, additional, Chiu, W-C, additional, Chu-Sung Hu, S, additional, Lu, C-W, additional, Yang, Y-F, additional, Chiu, C-C, additional, Ou-Yang, F, additional, Wang, Y-M, additional, Hou, M-F, additional, and Yuan, S-SF, additional

Published
2017
Full Text
View/download PDF

10. SLUG is required for SOX9 stabilization and functions to promote cancer stem cells and metastasis in human lung carcinoma

Author

Luanpitpong, S, primary, Li, J, additional, Manke, A, additional, Brundage, K, additional, Ellis, E, additional, McLaughlin, S L, additional, Angsutararux, P, additional, Chanthra, N, additional, Voronkova, M, additional, Chen, Y C, additional, Wang, L, additional, Chanvorachote, P, additional, Pei, M, additional, Issaragrisil, S, additional, and Rojanasakul, Y, additional

Published
2015
Full Text
View/download PDF

11. Resistin facilitates breast cancer progression via TLR4-mediated induction of mesenchymal phenotypes and stemness properties

Author

Wang, C-H, Wang, P-J, Hsieh, Y-C, Lo, S, Lee, Y-C, Chen, Y-C, Tsai, C-H, Chiu, W-C, Chu-Sung Hu, S, Lu, C-W, Yang, Y-F, Chiu, C-C, Ou-Yang, F, Wang, Y-M, Hou, M-F, and Yuan, S-SF

Abstract

Growing evidence indicates that resistin—an obesity-related cytokine—is upregulated in breast cancer patients, yet its impact on breast cancer behavior remains to be ascertained. Similarly, Toll-like receptor 4 (TLR4) has been implicated in breast cancer progression, however, its clinically relevant endogenous ligand remains elusive. In this study, we observed that high serum resistin levels in breast cancer patients positively correlated with tumor stage, size and lymph node metastasis. These findings were replicated in animal models of breast cancer tumorigenesis and metastasis. Resistin was found to promote epithelial–mesenchymal transition and stemness in breast cancer cells—mechanisms critical to tumorigenesis and metastasis—through a TLR4/nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)/signal transducer and activator of transcription 3 (STAT3) signaling pathway and negated by TLR4-specific antibody and antagonist. These findings provide clear evidence that resistin is a clinically relevant endogenous ligand for TLR4, which promotes tumor progression via TLR4/NF-κB/STAT3 signaling, providing insights into a novel therapeutic target in breast cancer.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results